Increasing Complexity of Farnesyltransferase Inhibitors Activity: Role in Chromosome Instability

E-ISSN： 1873-5576|3|2|109-118

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.2, 2003-04, pp. : 109-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesyltransferase Inhibitors: Potential Role in the Treatment of Cancer

By Cox A.D.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

Non-peptidic, Non-prenylic Bisubstrate Farnesyltransferase Inhibitors, 4. Effect on Farnesyltransferase Inhibitory Activity of Conformational Restrictions in the Central Group

By Schlitzer M. Sattler I.

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 3, 2000-03 ,pp. : 117-124

Pharmaceutical Press

Access to resources Recommend Favorite

Non-Peptidic, Non-Prenylic Bisubstrate Farnesyltransferase Inhibitors. Effect of a Carboxyl Group at the Central Group on Farnesyltransferase Inhibitory Activity

By Schlitzer M. Sattler I.

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 11, 2000-11 ,pp. : 507-512

Pharmaceutical Press

Access to resources Recommend Favorite

Farnesyltransferase Inhibitors: Overview of their Action and Role in Solid Malignancy Therapy

Letters in Drug Design & Discovery, Vol. 2, Iss. 1, 2005-02 ,pp. : 26-35

Bentham Science Publishers

Access to resources Recommend Favorite

Protein farnesyltransferase inhibitors

By Head Julia E Johnston Stephen RD

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 163-178

Informa Healthcare

Access to resources Recommend Favorite